20/20 GeneSystems, Inc.
9430 Key West Ave.
Rockville, MD 20850
July 15, 2020
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attn: Cara Wirth
Re: | 20/20 GeneSystems, Inc. |
Offering Statement on Form 1-A | |
Post-Qualification Amendment No. 1 | |
Filed July 8, 2020 | |
File No. 024-11056 |
Dear Ms. Wirth:
We understand that the staff of the U.S. Securities and Exchange Commission (the “Commission”) has completed its review of the Post-Qualification Amendment No. 1 to Offering Statement on Form 1-A (the “Offering Statement”) of 20/20 GeneSystems, Inc. (the “Company”) and we hereby request that the Commission approve the qualification of the Offering Statement as of 4:00 PM Eastern Time on Friday, July 17, 2020.
We request that we be notified of such qualification by a telephone call to Mr. Louis A. Bevilacqua at (202) 869-0888 ext. 100. We also respectfully request that a copy of the written order from the Commission verifying the date and time of qualification of the Company’s Offering Statement be sent to Louis A. Bevilacqua via email at lou@bevilacquapllc.com
Sincerely, | ||
20/20 GeneSystems, Inc. | ||
By: | /s/ Jonathan Cohen | |
Jonathan Cohen | ||
Chief Executive Officer |
cc: | Louis A. Bevilacqua, Esq. |